{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:20:09Z","timestamp":1740633609715,"version":"3.38.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg Cases"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Thymic carcinoma is a rare type of tumor originating in the thymus, making up about 15\u201320% of all thymic epithelial tumors. It typically has a poor prognosis, especially in advanced stages, with low 5-year survival rates. Cases where the cancer recurs more than 10\u00a0years after surgery are extremely uncommon. Additionally, there are very few reports about the outcomes of patients who undergo aortic resection as part of their treatment for thymic carcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 68-year-old male was diagnosed with thymic squamous cell carcinoma classified as Masaoka stage III following the detection of an anterior mediastinal mass during a routine health examination. The patient underwent preoperative treatment, which included two cycles of chemotherapy (cisplatin and docetaxel) and 60\u00a0Gy of mediastinal radiotherapy, followed by an extensive surgical procedure comprising extended thymectomy, resection of the ascending aorta and superior vena cava, and wedge resection of the right upper lobe. Postoperative pathological examination revealed ypT3N0M0 disease, corresponding to ypStage IIIa disease, and the patient remained disease-free for 10\u00a0years. However, at 11\u00a0years after surgery, imaging revealed new nodules in the left lung. Surgical resection confirmed these nodules as metastatic lesions originating from the thymic carcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This case highlights the critical need for long-term monitoring of thymic carcinoma patients, extending beyond the standard 5-year follow-up due to the potential for late recurrence, even in initially disease-free patients. Furthermore, our findings indicate that aortic resection, when carefully selected, can contribute to favorable long-term outcomes in advanced cases. This report enhances the limited literature on the long-term prognosis of thymic carcinoma, particularly following major vascular resection, and underscores the importance of a multidisciplinary approach to optimize patient management and improve outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s44215-025-00190-w","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:55:46Z","timestamp":1740567346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thymic carcinoma recurring 11\u00a0years post-extended surgery: a case report"],"prefix":"10.1186","volume":"4","author":[{"given":"Kiyoki","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachi","family":"Kawagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2540-5288","authenticated-orcid":false,"given":"Yasushi","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"190_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","volume":"9","author":"E Ruffini","year":"2014","unstructured":"Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, Brunelli A, Guerrera F, Keshavjee S, Altorki N, et al. Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol. 2014;9:541\u20138. https:\/\/doi.org\/10.1097\/JTO.0000000000000128.","journal-title":"J Thorac Oncol"},{"key":"190_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.athoracsur.2012.09.006","volume":"95","author":"B Weksler","year":"2013","unstructured":"Weksler B, Dhupar R, Parikh V, Nason KS, Pennathur A, Ferson PF. Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg. 2013;95:299\u2013303. https:\/\/doi.org\/10.1016\/j.athoracsur.2012.09.006.","journal-title":"Ann Thorac Surg"},{"key":"190_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ejcts\/ezv239","volume":"49","author":"T Hishida","year":"2016","unstructured":"Hishida T, Nomura S, Yano M, Asamura H, Yamashita M, Ohde Y, Kondo K, Date H, Okumura M, Nagai K, et al. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg. 2016;49:835\u201341. https:\/\/doi.org\/10.1093\/ejcts\/ezv239.","journal-title":"Eur J Cardiothorac Surg"},{"key":"190_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1245\/s10434-015-4825-4","volume":"23","author":"H Fu","year":"2016","unstructured":"Fu H, Gu ZT, Fang WT, Fu JH, Shen Y, Han YT, Yu ZT, Li Y, Tan LJ, Pang LW, et al. Long-term survival after surgical treatment of thymic carcinoma: a retrospective analysis from the chinese alliance for research of thymoma database. Ann Surg Oncol. 2016;23:619\u201325. https:\/\/doi.org\/10.1245\/s10434-015-4825-4.","journal-title":"Ann Surg Oncol"},{"key":"190_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/0218492319848958","volume":"27","author":"H Yabuki","year":"2019","unstructured":"Yabuki H, Minowa M. Long survival and recurrence of thymic carcinoma 10 years after resection. Asian Cardiovasc Thorac Ann. 2019;27:407\u20139. https:\/\/doi.org\/10.1177\/0218492319848958.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"190_CR6","doi-asserted-by":"publisher","first-page":"E139","DOI":"10.1016\/j.athoracsur.2016.01.014","volume":"102","author":"T Momozane","year":"2016","unstructured":"Momozane T, Inoue M, Shintani Y, Funaki S, Kawamura T, Minami M, Shirakawa Y, Kuratani T, Sawa Y, Okumura M. Trimodality therapy for an advanced thymic carcinoma with both aorta and vena cava invasion. Ann Thorac Surg. 2016;102:E139\u201341. https:\/\/doi.org\/10.1016\/j.athoracsur.2016.01.014.","journal-title":"Ann Thorac Surg"},{"key":"190_CR7","doi-asserted-by":"publisher","first-page":"ARTN e25331","DOI":"10.1097\/MD.0000000000025331","volume":"100","author":"JY Wu","year":"2021","unstructured":"Wu JY, Wang ZJ, Jing CB, Hu Y, Yang B, Hu YP. The incidence and prognosis of thymic squamous cell carcinoma: a surveillance, epidemiology, and end results program population-based study. Medicine. 2021;100:ARTN e25331. https:\/\/doi.org\/10.1097\/MD.0000000000025331.","journal-title":"Medicine"},{"key":"190_CR8","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.athoracsur.2009.11.057","volume":"89","author":"Y Hosaka","year":"2010","unstructured":"Hosaka Y, Tsuchida M, Toyabe S, Umezu H, Eimoto T, Hayashi J. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg. 2010;89:912\u20137. https:\/\/doi.org\/10.1016\/j.athoracsur.2009.11.057.","journal-title":"Ann Thorac Surg"},{"key":"190_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejcts.2009.02.019","volume":"36","author":"CY Lee","year":"2009","unstructured":"Lee CY, Bae MK, Park IK, Kim DJ, Lee JG, Chung KY. Early Masaoka stage and complete resection is important for prognosis of thymic carcinoma: a 20-year experience at a single institution. Eur J Cardio-Thorac. 2009;36:159\u201363. https:\/\/doi.org\/10.1016\/j.ejcts.2009.02.019.","journal-title":"Eur J Cardio-Thorac"},{"key":"190_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11748-014-0486-7","volume":"63","author":"Y Shintani","year":"2015","unstructured":"Shintani Y, Inoue M, Kawamura T, Funaki S, Minami M, Okumura M. Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution. Gen Thorac Cardiovasc Surg. 2015;63:159\u201363. https:\/\/doi.org\/10.1007\/s11748-014-0486-7.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"190_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s0003-4975(03)00831-2","volume":"76","author":"YL Tseng","year":"2003","unstructured":"Tseng YL, Wang ST, Wu MH, Lin MY, Lai WW, Cheng FF. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg. 2003;76:1041\u20135. https:\/\/doi.org\/10.1016\/s0003-4975(03)00831-2.","journal-title":"Ann Thorac Surg"},{"key":"190_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF03218079","volume":"48","author":"K Oyama","year":"2000","unstructured":"Oyama K, Onuki T, Mae M, Adachi T, Kanzaki M, Murasugi M, Sone Y, Kei J, Yokoyama M, Nitta S. Combined thoracic aortic or upper digestive tract resection for lung cancer and malignant mediastinal tumor. Jpn J Thorac Cardiovasc Surg. 2000;48:9\u201315. https:\/\/doi.org\/10.1007\/BF03218079.","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"190_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/BF03032300","volume":"50","author":"T Takahashi","year":"2002","unstructured":"Takahashi T, Suzuki K, Ito Y, Takinami M, Yamashita K, Kazui T. Aortic arch resection under temporary bypass grafting for advanced thymic cancer. Jpn J Thorac Cardiovasc Surg. 2002;50:302\u20134. https:\/\/doi.org\/10.1007\/BF03032300.","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"190_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13019-015-0346-2","volume":"10","author":"M Ried","year":"2015","unstructured":"Ried M, Neu R, Schalke B, von Susskind-Schwendi M, Sziklavari Z, Hofmann HS. Radical surgical resection of advanced thymoma and thymic carcinoma infiltrating the heart or great vessels with cardiopulmonary bypass support. J Cardiothorac Surg. 2015;10:137. https:\/\/doi.org\/10.1186\/s13019-015-0346-2.","journal-title":"J Cardiothorac Surg"},{"key":"190_CR15","doi-asserted-by":"publisher","first-page":"E557","DOI":"10.1016\/j.athoracsur.2016.05.095","volume":"102","author":"S Oka","year":"2016","unstructured":"Oka S, Taira A, Shinohara S, Kuwata T, Takenaka M, Chikaishi Y, Hirai A, Uramoto H, Nishimura Y, Tanaka F. Complete resection of thymic sarcomatoid carcinoma through total aortic arch replacement. Ann Thorac Surg. 2016;102:E557\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2016.05.095.","journal-title":"Ann Thorac Surg"},{"key":"190_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s40792-019-0713-7","volume":"5","author":"H Kuno","year":"2019","unstructured":"Kuno H, Funaki S, Kimura K, Shimamura K, Kin K, Kuratani T, Sawa Y, Shintani Y. Complete resection of local advanced thymic carcinoma with total aortic arch replacement after chemotherapy: a case report. Surg Case Rep. 2019;5:198. https:\/\/doi.org\/10.1186\/s40792-019-0713-7.","journal-title":"Surg Case Rep"},{"key":"190_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13019-020-01354-1","volume":"15","author":"H Yamato","year":"2020","unstructured":"Yamato H, Funaki S, Shimamura K, Kin K, Kuratani T, Sawa Y, Shintani Y. Salvage surgery for stage IVa thymic carcinoma combined with aortic arch resection - case report. J Cardiothorac Surg. 2020;15:305. https:\/\/doi.org\/10.1186\/s13019-020-01354-1.","journal-title":"J Cardiothorac Surg"},{"key":"190_CR18","doi-asserted-by":"publisher","unstructured":"Hamaji M, Allen MS, Cassivi SD, Nichols FC 3rd, Wigle DA, Deschamps C, Shen KR. The role of surgical management in recurrent thymic tumors. Ann Thorac Surg 2012;94:247-254. https:\/\/doi.org\/10.1016\/j.athoracsur.2012.02.092. discussion 254.","DOI":"10.1016\/j.athoracsur.2012.02.092"},{"key":"190_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/ol.2013.1327","volume":"6","author":"G Toyokawa","year":"2013","unstructured":"Toyokawa G, Taguchi K, Kojo M, Toyozawa R, Inamasu E, Morodomi Y, Shiraishi Y, Takenaka T, Hirai F, Yamaguchi M, et al. Recurrence of thymic neuroendocrine carcinoma 24 years after total excision: a case report. Oncol Lett. 2013;6:147\u20139. https:\/\/doi.org\/10.3892\/ol.2013.1327.","journal-title":"Oncol Lett"},{"key":"190_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s44215-023-00124-4","volume":"2","author":"S Hayashi","year":"2023","unstructured":"Hayashi S, Matsushima K, Mikubo M, Tochimoto M, Ichinoe M, Satoh Y. Pleural recurrence 21 years after complete resection of thymic mucoepidermoid carcinoma: a case report. Gen Thorac Cardiovasc Surg Cases. 2023;2:105. https:\/\/doi.org\/10.1186\/s44215-023-00124-4.","journal-title":"Gen Thorac Cardiovasc Surg Cases"},{"key":"190_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000502656","volume":"103","author":"SH Yoo","year":"2019","unstructured":"Yoo SH, Kim H, Kwak C, Kim HH, Jung JH, Ku JH. Late Recurrence of bladder cancer following radical cystectomy: characteristics and outcomes. Urol Int. 2019;103:291\u20136. https:\/\/doi.org\/10.1159\/000502656.","journal-title":"Urol Int"},{"key":"190_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/jnci\/djab202","volume":"114","author":"RN Pedersen","year":"2022","unstructured":"Pedersen RN, Esen BO, Mellemkjaer L, Christiansen P, Ejlertsen B, Lash TL, Norgaard M, Cronin-Fenton D. The incidence of breast cancer recurrence 10\u201332 years after primary diagnosis. J Natl Cancer Inst. 2022;114:391\u20139. https:\/\/doi.org\/10.1093\/jnci\/djab202.","journal-title":"J Natl Cancer Inst"},{"key":"190_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14:611\u201322. https:\/\/doi.org\/10.1038\/nrc3793.","journal-title":"Nat Rev Cancer"}],"container-title":["General Thoracic and Cardiovascular Surgery Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44215-025-00190-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44215-025-00190-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44215-025-00190-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:55:49Z","timestamp":1740567349000},"score":1,"resource":{"primary":{"URL":"https:\/\/gtcscases.biomedcentral.com\/articles\/10.1186\/s44215-025-00190-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1186\/s44215-025-00190-w","relation":{},"ISSN":["2731-6203"],"issn-type":[{"value":"2731-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethical Review Board for Clinical Studies of Osaka University Hospital (control number: 10026).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent was obtained from the patient for the publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}